Clinical Trials Logo
  1. Home
  2. Herpes Genitalis
  3. NCT04950712

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Herpes Genitalis Clinical Trial

Official title:
A Descriptive, Prospective, Multi-country, Multicentre Study to Assess Performance of Genital Herpes Simplex Virus-2 (HSV-2) Related Disease Endpoints Based on Patient-reported Health Outcomes, Self-swabbing Collected Via Decentralised Approach in Patients ≥ 18 Years of Age in the United States and Europe.

Clinical Trial Summary

The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well as the performance study procedures in a decentralised setting. Ultimately, this study will allow generating additional real-world evidence (RWE) on patterns of recurrences and other key parameters.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04950712
Study type Observational
Source GlaxoSmithKline
Contact
Status Active, not recruiting
Phase
Start date June 9, 2021
Completion date April 9, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT02837575 - Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine Phase 2
Completed NCT02852876 - Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food Phase 1
Completed NCT04664127 - Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
Completed NCT00405821 - Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda Phase 2
Completed NCT04165122 - Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection Phase 2
Completed NCT00158483 - Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) Phase 2
Terminated NCT00079911 - A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons Phase 4
Completed NCT00486200 - A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes Phase 2
Completed NCT00158860 - A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. Phase 4
Active, not recruiting NCT00005663 - A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients Phase 3
Active, not recruiting NCT04073082 - Safety and Efficacy of Laser Therapy in Gynaecology
Terminated NCT00122525 - Effect of Male Circumcision on HIV Incidence (ANRS 1265) Phase 3
Completed NCT00158509 - Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding Phase 2
Completed NCT00076232 - A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes Phase 3
Completed NCT00023582 - HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru N/A